This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:physicians:concerns [02.09.2019] – [Concerns about lack of clinical evidence] sallieq | home:physicians:concerns [06.01.2019] – [Physicians' concerns about the Marshall Protocol] sallieq | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Physicians' | ====== Physicians' | ||
+ | |||
+ | < | ||
Over the years, physicians have voiced various concerns about the Marshall Protocol, concerns ranging from the safety of higher doses of olmesartan (Benicar) to concerns about long-term antibiotic use. The Autoimmunity Research Foundation has assembled articles, well-grounded in scientific research, which address these concerns. Physicians who choose to use and administer the MP do so on the basis of the [[home: | Over the years, physicians have voiced various concerns about the Marshall Protocol, concerns ranging from the safety of higher doses of olmesartan (Benicar) to concerns about long-term antibiotic use. The Autoimmunity Research Foundation has assembled articles, well-grounded in scientific research, which address these concerns. Physicians who choose to use and administer the MP do so on the basis of the [[home: | ||
Line 16: | Line 18: | ||
For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | ||
* evidence for the efficacy of MP versus other available treatment options(({{pubmed> | * evidence for the efficacy of MP versus other available treatment options(({{pubmed> | ||
+ | * more recent material on patient response, see below update | ||
* patients' | * patients' | ||
* additional benefits of Olmesartan [[https:// | * additional benefits of Olmesartan [[https:// | ||
Line 24: | Line 27: | ||
< | < | ||
- | ===== Numerical improvements update | + | ===== Recorded success rates assessed 2013 |
< | < | ||
Line 103: | Line 106: | ||
==== Read also ==== | ==== Read also ==== | ||
+ | |||
+ | [[http:// | ||
**Evaluation of the Effect of Radiofrequency Radiation Emitted From Wi-Fi Router and Mobile Phone Simulator on the Antibacterial Susceptibility of Pathogenic Bacteria Listeria monocytogenes and Escherichia coli.**\\ Altogether, the findings of this study showed that exposure to Wi-Fi and RF simulator radiation can significantly alter the inhibition zone diameters and growth rate for L monocytogenes and E coli. These findings may have implications for the management of serious infectious diseases. | **Evaluation of the Effect of Radiofrequency Radiation Emitted From Wi-Fi Router and Mobile Phone Simulator on the Antibacterial Susceptibility of Pathogenic Bacteria Listeria monocytogenes and Escherichia coli.**\\ Altogether, the findings of this study showed that exposure to Wi-Fi and RF simulator radiation can significantly alter the inhibition zone diameters and growth rate for L monocytogenes and E coli. These findings may have implications for the management of serious infectious diseases. | ||
Line 111: | Line 116: | ||
{{tag> | {{tag> | ||
+ | |||
+ | [[home: | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||